Objectives: To evaluate the effect of leukocyte and platelet-rich fibrin (L-PRF) in combination with deproteinized bovine bone mineral (DBBM) on bone regeneration in maxillary sinus augmentation.
| INTRODUCTION
The insufficient height of the residual bone in the edentulous posterior maxilla is a common difficulty for the reconstruction of the area with implant-supported prostheses. Maxillary sinus pneumatization together with the progressive resorption of alveolar bone is the major cause of the insufficient bone volume in the area (Boyne & James, 1980; Brånemark et al., 1984) . To date, different sinus augmentation approaches have been described using autogenous bone and/ or bone substitute aiming to facilitate the proper placement of the implants in the severely resorbed posterior maxilla (Esposito, Felice & Worthington, 2014; Schmitt, Moest, Lutz, Neukam & Schlegel, 2015; Schmitt et al., 2013) . Lateral window approach, either alone or with simultaneous implant placement, is the most preferred and welldocumented sinus augmentation technique in such cases (Corbella, Taschieri & Del Fabbro, 2015) .
Even though satisfactory clinical outcomes using various biomaterials have been achieved in sinus augmentation (Corbella, Taschieri, Weinstein & Del Fabbro, 2016) , there is still a search to investigate optimal material combinations and/or conditions to enhance bone regeneration properties and long-term stability of the site. The limited volume of augmented bone in the sinus area following augmentation procedures and the limited source for autogenous bone grafts together with high morbidity rates of patients are important factors that encourage the clinicians to use xenografts and bone substitutes rather than the autogenous grafts (Shanbhag, Shanbhag & Stavropoulos, 2014) .
Although the xenografts and the bone substitutes lack osteoinductive (Donos, Kostopoulos, Tonetti, Karring & Lang, 2006) and osteogenic properties, their osteoconductive properties have been shown in preclinical and clinical studies (Donos, Dereka & Mardas, 2015; Donos et al., 2005; Miron & Zhang, 2012; Stavropoulos & Karring, 2010) .
Deproteinized bovine bone mineral (DBBM) has frequently been preferred as single grafting material for maxillary sinus augmentation. Accordingly, most of the studies have demonstrated not only successful histological and clinical outcomes but also prolonged graft-healing time that can be explained by non-resorbing characteristic of the graft (Browaeys, Bouvry & De Bruyn, 2007; Corbella et al., 2016; Jensen, Schou, Stavropoulos, Terheyden & Holmstrup, 2012) .
Deproteinized bovine bone mineral does not activate new bone formation by itself, and hence, mixing the graft material with a biologic enhancer that include essential growth factors involved in bone formation pattern may reduce the graft-healing time and complement osteoinductive process of new bone formation (Castro et al., 2017) .
Platelet-rich fibrin (PRF) is an autologous platelet concentrate that contains platelet-derived growth factor (PDGF), insulin-like growth factor (IGF), vascular endothelial growth factor (VEGF), transforming growth factor beta (TGF-β), and platelet-derived angiogenic factor (Peterson et al., 2010) . Moreover, platelets secrete fibrin, fibronectin, and vitronectin, which modulate soft and hard tissue response, behave as a matrix for the connective tissue and adhesion molecules resulting in more efficient cell recruitment in wound area (De Pascale, Sommese, Casamassimi & Napoli, 2015) . The terminology of PRF has been changed to L-PRF (Dohan et al., 2014) due to its higher leukocyte content (Fujioka-Kobayashi et al., 2017) and still belongs to the second generation of platelet concentrates (Castro et al., 2017) . In this study, the term PRF or L-PRF is determined according to their reference citation for terminological clarification. PRF has been used as a membrane in guided tissue regeneration (Thorat, Pradeep & Pallavi, 2011) , as a tissue replacement material in root coverage (Eren & Atilla, 2014) and as a graft material in maxillary sinus augmentation procedures (Mazor et al., 2009; Zhang et al., 2012) . PRF has also been used alone or in combination with xenografts aiming to promote bone regeneration and increase the amount of newly formed bone by enhancing osteoprogenitor cells in the grafted area Oliveira et al., 2015) . Higher numbers of platelets in the wound area may result in subsequent platelet activation and aggregation that serve as a molecular glue (De Pascale et al., 2015) . Nevertheless, up to date, the clinical advantages of L-PRF when used in combination with DBBM still remain controversial. Therefore, the aim of the present split-mouth study is to evaluate whether L-PRF improves the efficacy of DBBM on bone regeneration in maxillary sinus augmentation.
| MATERIALS AND METHODS

| Patient population
This clinical study was designed as a split-mouth, randomized, con- 49.92 ± 10.37) in need of bilateral sinus lift procedures. The procedures were explained in detail to all patients before enrollment into the study, and written informed consent statements were received.
The inclusion criteria were as follows: systemically healthy, age ≥21 years, having requirement of implant therapy in bilateral posterior maxilla with residual bone height <5 mm (sufficient interarch space and/or not in need of vertical bone augmentation) and being periodontally healthy [full mouth plaque score and bleeding score less than 20% (Ainamo & Bay, 1975; O'Leary, Drake & Naylor, 1972) ]. Exclusion criteria were as follows: the presence of any systemic disease, usage of any medications that could interfere with bone metabolism (i.e., corticosteroids, bisphosphonate), smoking, having history of maxillary sinusitis or sinus surgery, history of reconstructive or previous implant surgery, and being edentulous for a period of <1 year. Clinical parameters including full mouth plaque and bleeding scores as well as probing depth (mm) were recorded by single calibrated examiner (G.E.; intraclass correlation coefficient was .93).
Bilateral maxillary sinuses were randomly assigned to either the test (DBBM (BioOss, Geitslich AG, Wolhusen, Switzerland) + L-PRF) or the control (DBMM) immediately before the surgery using computergenerated lists.
| L-PRF preparation
L-PRF was prepared as described previously (Eren & Atilla, 2014) .
Briefly, peripheral blood samples of patients were taken at the beginning of the surgery and immediately centrifuged using a table centrifuge (Nüve Laboratory Equipments, NF200, Ankara, Turkey) for 12 min at 400 × g. After centrifugation, the fibrin clot was removed from the tube and separated by microsurgical scissor. The L-PRF clots were placed in a metal box and were prepared in the form of a membrane by squeezing out the fluids present in the fibrin clot ( Figure 1a) . Then, the clots transferred into a metal cup and cut into fragments with the microsurgical scissor ( Figure 1b ) to mix with DBBM (≈1.5 gr, large granule (1-2 mm particle size) for each sinus; Figure 1c ).
| Maxillary sinus augmentation
A lateral window approach for maxillary sinus augmentation was utilized (Tatum, 1986) . The interventions were planned as a two-stage surgery and sinus augmentation was performed simultaneously on both sides. All surgical procedures were performed under local anesthesia by the same surgeon (N.N.). Mid-crestal, mesial, and distal releasing incisions were made to elevate a full thickness flap on the buccal aspect. Lateral wall of the sinus was demarcated using rotary instruments, and the lateral wall was then removed carefully as one piece. Lifting of the schneiderian membrane medially and superiorly was achieved using hand instruments. When partial septum was present, the membrane was elevated around it, and in the presence of full septum, two separate windows were created.
Deproteinized bovine bone mineral (BioOss, Geitslich AG, Wolhusen, Switzerland) was mixed with L-PRF (test) or was used alone (control). The material was placed gently into the sinus with a periosteal elevator without compressing the graft material until the desired vertical height was achieved. The removed lateral wall of the sinus was repositioned, and a resorbable membrane (25 × 25 mm) (BioGide, Geitslich AG, Wolhusen, Switzerland) was adapted to cover the lateral window. The flap was then repositioned and sutured to achieve a primary wound closure.
Antibiotic prophylaxis was used in all cases 1 hr before surgery (2 gr amoxicillin), and (6 days, twice a day) 1 gr amoxicillin was prescribed postoperatively to reduce the risk of postoperative infections.
After a healing period of 6 months, a single bone biopsy was harvested from each sinus during implant site preparation using a standard trephine drill (Hager & Meisinger GmbH, Neuss, Germany) with an inner diameter of 3.0 mm. The site of the biopsy corresponded to the implant site with the lowest amount of preoperative residual bone.
The biopsy was harvested in vertical direction and deep enough to obtain bone from the augmented area. A bone core approximately 3.0 mm in diameter and 8-10 mm in length was removed from the crest of the ridge. A total of 58 bone level implants [Institut Straumann AG, Basel, Switzerland (test: 11 and control: 11) and Zimmer TSV Implant System, Carlsbad, CA, USA (test: 19 and control: 17)] with diameters between 4.1 and 6.0 Ø and length between 10 and 13 mm were placed in 26 augmented maxillary sinus area with the same implant system being used in the same patient. No additional augmentation procedures were required during the surgery, and implants were placed in line with the treatment plan of the patient. After the osseointegration period of 6 months, porcelain fused to metal crowns was fabricated and all the patients were followed 12 months after implant loading.
Radiographic residual (baseline) and augmented bone height (after 6 months) was evaluated using digital panoramic radiograph (Kodak 8000C; Eastman Kodak Company, Rochester, NY). Bone height (distance from the alveolar crest to the most zenithal point of the augmented volume) was measured (G.E.; intraclass correlation coefficient was .91) linearly on radiographic images using a digital analysis program (ImageJ Windows, National Institutes of Health, Bethesda, MD) and expressed in millimeters (Nizam, Bengisu & Sönmez, 2015) .
| Histology processing and histomorphometric analysis
The collected biopsies were immediately fixed in 10% neutralbuffered formalin and processed. The specimens were dehydrated in increasing concentration of alcohols (70%, 95%, and 100%) and finally embedded in polymethylmethacrylate resin (OsteoBed, Polysciences).
Non-decalcified serial sections (50 μm thickness) (two sections per sample) cut longitudinally to the long axis of the sample were obtained using a Leiz 1600 diamond blade rotatory microtome. Histological assessment was performed considering the central section of the samples that has been stained with Goldner's trichrome for histomorphometric analysis by optical microscope. 
| Outcome
The primary outcome of this study was the percentage of newly formed bone, residual bone graft, and newly formed bone-to-bone graft contact in ROI.
Secondary outcomes included were the changes in radiographic augmented bone height 6 months after augmentation as well as implant survival rate 12 months after implant loading. the variables between groups were compared using unpaired t test.
| Statistical analysis
Implant survival rate was defined as all implants in place and was compared using chi-square test. A p < .05 was considered to represent statistically significant differences between the groups.
| RESULTS
Patient demographics and clinical data are provided in Table 1 . The mean residual bone height in the deepest portion of the maxillary sinus floor was 2.45 ± 0.79 in the test group and 2.53 ± 0.61 in the control group, and the difference was similar (p > .05).
No complication was observed during the sinus augmentation surgery except one patient (both sides of the patient) who had significant bleeding. The bleeding was controlled successfully and the patient completed the study. Sinus membrane perforation was not observed in any of the patients.
| Histological and histomorphometric findings
Twenty-one of the 26 biopsy specimens were suitable for a histomorphometric analysis.
Regarding the histology, no difference from a qualitative point of view was evident (Figure 2) . In all samples, a newly formed bone was in direct contact with the residual grafting materials (Figure 3 ).
There was no quantitative difference in the histomorphometric parameters among the groups ( 
| Clinical and radiographic findings
After 6 months following the augmentation, both maxillary sinuses and irrespective of the treatment provided showed a similar radiographic appearance in all patients. Similar radiographic bone height
T A B L E 1 Patient demographics and clinical data
Control Test
Age ( in the augmented area was observed between the two groups (test:
13.60 ± 1.09 and control: 13.53 ± 1.20; p = .88; Table 1 ).
Integration of the bone graft into newly formed bone was sufficient to allow implant placement at second-stage surgery in all patients.
Healing was uneventful in all patients during the osseointegration period, and there was no significant pain and sign or symptom of infection. Implant survival rate in the augmented maxillary sinus area 12 month after implant loading was 100% for both groups (Figure 4 ).
| DISCUSSION
The present study investigated the effect of L-PRF when combined with DBBM on bone augmentation in maxillary sinus. The histological and histomorphometric analysis revealed that both interventions have similar effect in terms of the percentage of newly formed bone, residual bone graft, and newly formed bone-to-bone graft contact in ROI.
From a biological perspective, DBBM is osteoconductive and allows osteogenic cell transport from the sinus wall around the graft particles (Browaeys et al., 2007; Tadjoedin, de Lange, Bronckers, Lyaruu & Burger, 2003) . In order to enhance the osteogenic potential and initiate new bone formation in maxillary sinus augmentation, the addition of autogenous bone grafts to the bone grafts/substitutes was recommended (Rickert, Slater, Meijer, Vissink & Raghoebar, 2012 ).
However, a recent systematic review demonstrated that DBBM alone and the combination with autogenous bone resulted in similar outcomes in maxillary sinus augmentation (Jensen et al., 2012) . Therefore, the control group in the present study received only DBBM as the graft material.
Patients' age, gender, and the residual bone height were reported as relevant factors for the assessment of regenerated bone quantitatively using the bone biopsies obtained from augmented sinus area (Reich et al., 2016) . In the present study, to control certain factors, the same therapist/periodontist carried out all surgical procedures, the particle size was identical in all cases, and the biopsy regions were distributed similarly with identical residual bone heights. As trephine biopsy offers a non-invasive way of obtaining a sample from the site of implant installation, presence of debris from the regenerated bone during the drilling procedure, heat necrosis of the biopsy, and positioning errors of the trephine bur must be taken into account as the limitation of the technique. Although very few samples were excluded from the analyses in the present study, the criteria of their exclusion were low graft amount and fragmentation. Moreover, both baseline and augmented bone height were obtained through the analysis of conventional radiographs but not cone-beam computed tomography (CBCT). Although magnification factor was accounted for in the interpretation of the recorded measurements, utilization of the panoramic radiographs rather than advanced imaging present as a limitation of the study.
Platelets have beneficial effects on hard tissue healing by providing a source for growth factors (Chang, Tsai & Chang, 2010; De Pascale et al., 2015) . It has been suggested that PRF keeps circulating stem cells via its unique fibrin form, which can further promote angiogenesis and osteogenesis (De Pascale et al., 2015) . These advantages might be important when regenerating large cavities such as maxillary sinuses (Choukroun et al., 2006) . Moreover, PRF can increase osteoblast proliferation in vitro stimulating osteoprotegerin secretion in human osteoblasts (Chang et al., 2010) . PRF has been used alone or in combination with bone grafts in sinus augmentation procedures acting like a scaffold to increase bone formation and healing rate of bony defects Mazor et al., 2009; Zhao, Tsai & Chang, 2015) .
Adjunctive effects of PRF on bone regeneration in maxillary sinus were evaluated in a clinical study using similar materials with the present study (Zhang et al., 2012) . In this study, eleven sinuses from 10 patients were augmented using either DBBM/PRF mixture (six sinuses)
or DBBM alone (five sinuses) and no difference was reported regarding the new bone formation between groups (DBBM/PRF; 18.35 ± 5.62%
and DBMM; 12.95 ± 5.33%) (Zhang et al., 2012) . These results are in line with the present data; however, new bone formation seems to be higher in the present study for both groups (test; 21.38 ± 8.78% and control; 21.25 ± 5.59%), and this could be explained by the differences in the study design and patient characteristics.
In a recent report, four patients were treated using DBBM/PRF mixture and the percentages of newly formed bone of each patient were 31.7 ± 1.2%, 21.0 ± 1.0% and 38.0 ± 0.6% after 7 months and 47.0 ± 0.6% after 10 months (Tanaka et al., 2015) . Even though the rates reported by Tanaka et al., 2015 seem to be higher compared to the present study, the small sample size, the longer healing period, and the absence of control group do not allow any comparisons. Valentini & Abensur, 2003) . However, the adequate healing period of xenogeneic grafts in maxillary sinus augmentation is still questioned whether the predicted healing period is enough to achieve an optimum bone volume for correct implant placement. A 6-month healing period is reported as adequate according to the previous reports (Lee et al., 2006; Valentini, Abensur, Wenz, Peetz & Schenk, 2000) and a recent randomized, controlled, clinical, and histological investigation further confirmed this period and suggested reduced healing period to 3 months following sinus augmentation with DBBM (Kohal et al., 2015) . Even though similar results were obtained in both groups in the present study at 6 month, it is not yet known whether the 3 months' results would differ between the groups indicating an earlier implant placement after L-PRF/DBBM combination.
Bio-resorption capacity is a basic property of a biomaterial (Blokhuis et al., 2000) . The graft may disappear partially or completely over time and facilitate new bone formation (Blokhuis et al., 2000; Shanbhag et al., 2014) . However, there is still controversy in terms of the resorptive capacity of DBBM in the literature and even several years after augmentation the graft material was still present in the augmented area (Schlegel, Fichtner, Schultze-Mosgau & Wiltfang, 2003; Traini, Valentini, Iezzi & Piattelli, 2007) . A recent study in a rabbit model compared the resorption rates of the PRF, DBBM and biphasic calcium phosphate (Ezirganli, Kazancioglu, Mihmanli, Sharifov & Aydin, 2015) . The resorption rate of PRF was much greater, and total bone volume was lower at the sixth month compared to other groups.
However, the result of the present study demonstrated that L-PRF did not affect the resorptive capacity of DBBM, at least by the 6th month, as the bone substitute volume per tissue volume was similar in both groups.
Even though a recent systematic review on histomorphometric evaluation of sinus floor elevation with L-PRF has been reported possible positive effect of L-PRF on bone regeneration, the present data could not confirm this effect (Castro et al., 2017) . As the clinical importance of this technique lies to gaining maximum amount of regenerated bone at the future implant healing site, the additional use of L-PRF did not appear to improve the outcomes obtained with the use of DBBM alone after 6 months of healing. The similar outcomes of the two interventions could be explained by the long graft-healing time, which did not allow us to observe any potential accelerated bone formation within the initial healing period. As yet, this also creates a further question, on what would be the best graft-healing period that is essential for newly formed bone and also required for the initial stability of the implant? Therefore, the fact that similar outcomes were found in the two groups should be considered with great caution, and further, pragmatic trials on a wider (sample) population which would include earlier healing points should be performed.
| CONCLUSIONS
Both DBBM and L-PRF/DBBM combinations have similar histological outcomes for maxillary sinus augmentation following 6 months of healing. Randomized controlled clinical studies are needed to better understand the sequential response of wound healing in regenerative approaches when L-PRF is used alone or in combination with different biomaterials.
